5 completed. 5 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 5 |
| Phase 2 | 3 | Completed 3 |
Follow Diabetes Type 2: new trials by email Literature Review of Diabetes Type 2 trials Research Report on Diabetes Type 2
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Interaction Between Diabetes and Estradiol on Human Brain Metabolism in Postmenopausal Women Estradiol patch - Diabetes Type 2, Dementia | Phase 1 | Completed | Wake Forest University Health Sciences | 12 | 2019-05-13 | 2022-09-27 |
| A Study to Evaluate the Safety and Effectiveness of DM199 in Healthy Subjects and Type 2 Diabetes Patients DM199, Placebo - Diabetes Type 2 | Phase 1 / Phase 2 | Completed | DiaMedica Therapeutics Inc | 98 | 2013-04-01 | 2014-12-19 |
| Exploratory Study of Iocide Oral Rinse in a Diabetic Population Frio Mouth Rinse Placebo, Frio Mouth Rinse - Diabetes Type 2, Periodontitis | Phase 1 | Completed | Biomedical Development Corporation | 30 | 2008-12-01 | 2012-02-02 |
| Effects of Aliskiren, Irbesartan, and the Combination in Hypertensive Patients With Type 2 Diabetes and Diabetic Nephropathy Aliskiren - Diabetes Type 2 | Phase 1 / Phase 2 | Completed | Novartis | 24 | 2005-09-01 | 2007-11-29 |
| Time Course of the Antiproteinuric and Blood Pressure Lowering Effects After Initiation of Renin Inhibition With Aliskiren in Type 2 Diabetes Aliskiren - Diabetes Type 2 | Phase 1 / Phase 2 | Completed | Novartis | 18 | 2005-08-01 | 2016-09-23 |
Diabetes Mellitus, Type 2 (5) · Dementia (1) · Diabetes Mellitus (1) · Periodontitis (1)
Endocrine System Diseases (5) · Glucose Metabolism Disorders (5) · Metabolic Diseases (5) · Nutritional and Metabolic Diseases (5) · Diabetes Mellitus (4) · Brain Diseases (1) · Central Nervous System Diseases (1) · Mental Disorders (1) · Mouth Diseases (1) · Nervous System Diseases (1) · Neurocognitive Disorders (1) · Periodontal Diseases (1) · Stomatognathic Diseases (1)
aliskiren (2) · DM199 (1) · Ortho Evra (1)
Novartis (2) · Biomedical Development Corporation (1) · DiaMedica Therapeutics Inc (1) · Wake Forest University Health Sciences (1)
Denmark (2) · United States (2) · Netherlands (1)
Christina Hugenschmidt, PhD (1) · Salah Hadi, MD, MSc (1) · Thomas W. Oates, DMD, Ph.D. (1)
R21AG054955 (1)